吉田謙一郎　YOSHIDA KEN-ICHIROU　ヨシダ ケンイチロウ

研究者情報

研究者情報

• 氏名

  吉田謙一郎, ヨシダ ケンイチロウ

所属

• 学長, 学長

研究業績

論文

原著論文
• Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer, Kamai T, Tokura Y, Uematsu T, Sakamoto K, Suzuki I, Takei K, Narimatsu T, Kambara T, Yuki H, Betsunoh H, Abe H, Fukabori Y, Yashi M, Yoshida KI, Open Heart, 5（1）, e000666, 2018年01月

  DOI
• Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma, Nukui A, Yanai Y, Tsuzuki T, Abe H, Arai K, Yoshida KI, Kamai T, Oncotarget, 9（3）, 4188-4199, 2017年12月

  DOI
• Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy, Nukui A, Masuda A, Abe H, Arai K, Yoshida KI, Kamai T, BMC Cancer, 17（1）, 372, 2017年05月

  DOI
• Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma, Fukuda T, Kamai T, Masuda A, Nukui A, Abe H, Arai K, Yoshida K, Cancer Med, 5（8）, 1810-1820, 2016年08月

  DOI
• Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report, Kamai T, Abe H, Arai K, Murakami S, Sakamoto S, Kaji Y, Yoshida KI, BMC Cancer, 16, 232, 2016年03月

  DOI
• Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer., Mizuno T, Kamai T, Abe H, Sakamoto S, Kitajima K, Nishihara D, Yuki H, Kambara T, Betsunoh H, Yashi M, Fukabori Y, Kaji Y, Yoshida K, BMC Cancer, 15, 1097, 2015年03月

  DOI
• The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells, Abe H, Kamai T, Hayashi K, Anzai N, Shirataki H, Mizuno T, Yamaguchi Y, Masuda A, Yuki H, Betsunoh H, Yashi M, Fukabori Y, Yoshida K, BMC Cancer, 14, 412, 2014年06月

  DOI
• Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report., Yuki H, Kamai T, Kubota K, Abe H, Nishihara D, Mizuno T, Masuda A, Betsunoh H, Yashi M, Fukabori Y, Yoshida K, Onco Targets Ther, 7, 289-295, 2014年02月

  DOI
• Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma, Betsunoh H, Fukuda T, Anzai N, Nishihara D, Mizuno T, Yuki H, Masuda A, Yamaguchi Y, Abe H, Yashi M, Fukabori Y, Yoshida K, Kamai T, BMC Cancer, 13, 509, 2013年10月

  DOI
• Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma., Furuya N, Kamai T, Shirataki H, Yanai Y, Fukuda T, Mizuno T, Nakamura F, Kambara T, Nakanishi K, Abe H, Yoshida K, Cancer Immunol Immunother, 60（6）, 793-808, 2011年06月

  DOI
• Increased alpha-taxilin protein expression is associated with the metastatic and invasive potential of renal cell cancer., Mashidori T, Shirataki H, Kamai T, Nakamura F, Yoshida K, Biomed Res., 32（2）, 103-110, 2011年04月
• Randomized, placebo controlled study of electrical stimulation with pelvic floor muscle training for severe urinary incontinence after radical prostatectomy., Yamanishi T, Mizuno T, Watanabe M, Honda M, Yoshida K, J Urol, 184（5）, 2007-2012, 2010年11月

  DOI
• Efficacy of extended-release tolterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder., Watanabe M, Yamanishi T, Honda M, Sakakibara R, Uchiyama T, Yoshida K, Int J Urol, 17（11）, 931-936, 2010年11月

  DOI
• Prognostic significance of global grading system of Gleason score in patients with prostate cancer with bone metastasis., Kambara T, Oyama T, Segawa A, Fukabori Y, Yoshida K, BJU Int, 105（11）, 1519-1525, 2010年06月

  DOI
• Urodynamic effects of silodosin, a new alpha 1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia., Yamanishi T, Mizuno T, Tatsumiya K, Watanabe M, Kamai T, Yoshida K, Neurourol Urodyn, 29（4）, 558-562, 2010年04月

  DOI
• Single minimum incision endoscopic radical nephrectomy for renal tumors with preoperative virtual navigation using 3D-CT volume-rendering., Kamai T, Furuya N, Kambara T, Abe H, Honda M, Shioyama Y, Kaji Y, Yoshida K, BMC Urol, 10, 7, 2010年04月

  DOI
• Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer., Kamai T, Shirataki H, Nakanishi K, Furuya N, Kambara T, Abe H, Oyama T, Yoshida K, BMC Cancer, 10, 164, 2010年04月

  DOI
• Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging., Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K, J Magn Reson Imaging, 31（3）, 625-631, 2010年03月

  DOI
• Effects of Silodosin on Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia: Evaluation by Frequency/Volume Chart., Watanabe M, Yamanishi T, Mizuno T, Tatsumiya K, Masuda A, Honda M, Uchiyama T, Sakakibara R, Yoshida K, Low Urin Tract Symptoms, 2（1）, 31-36, 2010年02月

  DOI
• 後部尿道弁と間質性膀胱炎を合併した、小児難治性夜尿症の1例, 福田武彦, 山西友典, 神原常仁, 吉田謙一郎, 夜尿症研究, 15, 43-48, 2010年06月
• 膀胱癌診断における尿中サイトケラチン8・サイトケラチン18総量の臨床的有用性, 新井京子, 本田幹彦, 吉田謙一郎, Modern Media, 56（5）, 100-106, 2010年05月
• 過活動膀胱におけるソリフェナシンとプロピベリンの治療効果に関するクロスオーバー比較検討, 山西友典, 細谷吉克, 龍宮克尚, 渡辺美穂, 本田幹彦, 吉田謙一郎, 泌尿器外科, 23（3）, 287-293, 2010年03月